ABOUT THIS REPORT    |    HOME    |
In the Spotlight (2016 Highlights) Clover's vision and mission Clover at a glance Geographic footprint Group structure Our shareholders and shareholder Directorate
Introduction Chairman's report Chief Executive's report Chief Financial Officer's report Six year financial review Financial highlights
Overview of Clover's value creation Clover's business model CLOVER'S WAY FORWARD Way better value creation Clover's Timeline Clover's future value creation philosophy Strategy
Report on governance, risk and compliance Clover's risk universe King III Index Report of the Remuneration Committee Remuneration policy Remuneration mix Approach to executive remuneration Approach to non-executive director's remuneration Legacy scheme SARs issues
Six capital report Human capital Natural capital Manufactured capital Intellectual capital Social and relationship capital Financial capital Combined Assurance
Audit and risk committee report Approval of the financial statement Certificate by Company Secretary Independent Auditor's report Directors' report Consolidated statement of comprehensive income Consolidated statement of financial position Consolidated statement of changes in equity Consolidated statement of cash flows Notes to the consolidated financial statements Notes 1 - 10 Notes 11 - 20 Notes 21 - 30 Notes 31 - 34 Abbreviations Definitions
  • Clover's better way story and the shape of clover
  • Business review
  • How clover creates value
  • Governance, risk and compliance, and remuneration reports
  • Ethical operations – reporting on the 6 capitals
  • Annual financial statements
  •   BACK
  • In the Spotlight (2016 Highlights)
  • Clover's vision and mission
  • Clover at a glance
  • Geographic footprint
  • Group structure
  • Our shareholders and shareholder
  • Directorate
  •   BACK
  • Introduction
  • Chairman's report
  • Chief Executive's report
  • Chief Financial Officer's report
  • Six year financial review
  • Financial highlights
  •   BACK
  • Overview of Clover's value creation
  • Clover's business model
  • CLOVER'S WAY FORWARD
  • Way better value creation
  • Clover's Timeline
  • Clover's future value creation philosophy
  • Strategy
  •   BACK
  • Report on governance, risk and compliance
  • Clover's risk universe
  • King III Index
  • Report of the Remuneration Committee
  • Remuneration policy
  • Remuneration mix
  • Approach to executive remuneration
  • Approach to non-executive director's remuneration
  • Legacy scheme SARs issues
  •   BACK
  • Six capital report
  • Human capital
  • Natural capital
  • Manufactured capital
  • Intellectual capital
  • Social and relationship capital
  • Financial capital
  • Combined Assurance
  •   BACK
  • Audit and risk committee report
  • Approval of the financial statement
  • Certificate by Company Secretary
  • Independent Auditor's report
  • Directors' report
  • Consolidated statement of comprehensive income
  • Consolidated statement of financial position
  • Consolidated statement of changes in equity
  • Consolidated statement of cash flows
  • Notes to the consolidated financial statements
  • Notes 1 - 10
  • Notes 11 - 20
  • Notes 21 - 30
  • Notes 31 - 34
  • Abbreviations
  • Definitions

Annual financial statements

  • Audit and risk committee report
  • Approval of the financial statement
  • Certificate by Company Secretary
  • Independent Auditor's report
  • Directors' report
  • Consolidated statement of comprehensive income
  • Consolidated statement of financial position
  • Consolidated statement of changes in equity
  • Consolidated statement of cash flows
  • Notes to the consolidated financial statements
  • Notes 1 - 10
  • Notes 11 - 20
  • Notes 21 - 30
  • Notes 31 - 34
  • Abbreviations
  • Definitions

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

GROUP

   Notes  Ordinary share capital  Ordinary share premium  Other capital reserves  Cash flow hedge reserve  Foreign currency translation reserve  Retained earnings  Total  Non-controlling interests  Total equity 
R’000  R’000  R’000  R’000  R’000  R’000  R’000  R’000  R’000 
Balance at
1 July 2014 
   9 124  734 414  283 225     (5 582) 1 231 089  2 252 270  20 471  2 272 741 
Profit for the year                    350 345  350 345  (4 684) 345 661 
Other comprehensive income  21.1 - 21.2              3 268     3 268     3 268 
Total comprehensive income                 3 268  350 345  353 613  (4 684) 348 929 
Share appreciation rights exercised  19 263  103 949  (18 468)       (64 132) 21 612     21 612 
Share-based payment expense recognised  31       18 080           18 080     18 080 
Other capital reserves transferred to retained earnings           (209 957)       209 957          
Acquisition of non-controlling interest in Lactolab (Pty) Ltd                    (3 223) (3 223) (2 277) (5 500)
Dividends forfeited                    610  610     610 
Dividends declared and paid  9                (71 624) (71 624)    (71 624)
Balance at 30 June 2015     9 387  838 363  72 880     (2 314) 1 653 022  2 571 338  13 510  2 584 848 
Profit for the year                    350 906  350 906  995  351 901 
Other comprehensive income  21.1 - 21.2           2 412  26 461     28 873     28 873 
Total comprehensive income              2 412  26 461  350 906  379 779  995  380 774 
Share appreciation rights exercised  19  129  44 411  (11 709)       (23 638) 9 193     9 193 
Share-based payment expense recognised  31        12 697           12 697     12 697 
Initial recognition of call options  20        1 005           1 005     1 005 
Non-controlling interest arising from business combinations  3.1 - 3.2                       8 800  8 800 
Dividends forfeited                    155  155     155 
Dividends declared and paid  9                (108 755) (108 755)    (108 755)
Balance at
30 June 2016 
   9 516  882 774  74 873  2 412  24 147  1 871 690  2 865 412  23 305  2 888 717 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

COMPANY 

            Notes  Ordinary share capital  Ordinary share premium  Other capital reserves  Retained earnings  Total equity 
               R'000  R'000  R'000  R'000  R'000 
Balance at 1 July 2014              9 124  734 414  29 198  24 350  797 086 
Profit for the year                       78 177  78 177 
Other comprehensive income                       –  – 
Total comprehensive income                       78 177  78 177 
Share appreciation rights exercised           19  263  103 949  (18 468)    85 744 
Other capital reserves transferred to retained earnings                    ( 478) 478    
Dividends forfeited                       610  610 
Dividends declared and paid                       (71 624) (71 624)
Balance at 30 June 2015              9 387  838 363  10 252  31 991  889 993 
Profit for the year                       125 507  125 507 
Other comprehensive income                       –  – 
Total comprehensive income                       125 507  125 507 
                             
Share appreciation rights exercised           19  129  44 411  (8 083)    36 457 
Dividends forfeited                       155  155 
Dividends declared and paid                       (108 755) (108 755)
Balance at 30 June 2016              9 516  882 774  2 169  48 898  943 357 
Scroll
downloads
Integrated Report
Annual Financial Statements
PRODUCT GALLERY
AGM

Date: Monday, 28 November 2016 at 10am
Venue: Clover Headquarters
 Notice to AGM
  Proxy

CONTACT

Head Office
200 Constantia Drive, Constantia Kloof,
1709, Johannesburg
Tel: +27 (0)11 471 1400

downloads
Integrated Report
Annual Financial Statements
PRODUCT GALLERY
AGM

Date: Monday, 28 November 2016 at 10am
Venue: Clover Headquarters
 Notice to AGM
  Proxy

CONTACT

Head Office
200 Constantia Drive, Constantia Kloof,
1709, Johannesburg
Tel: +27 (0)11 471 1400

Sitemap
Disclaimer
 
Copyright Clover Limited 2016
Sitemap    
Disclaimer   Copyright Clover Limited 2016